-
QUANTIFYING CDA-INESSS DIFFERENCES IN ONCOLOGY HTA: RECOMMENDATIONS, RE-ANALYSIS, AND PRICE REDUCTIONS (2024-2025)
Feb 25, 2026, 14:43 PM -
FROM SINGLE-ARM EVIDENCE TO HTA-READY SURVIVAL COMPARISONS: EXTENDING MULTILEVEL NETWORK META-REGRESSION TO DISCONNECTED NETWORKS FOR TIME-TO-EVENT OUTCOMES IN NEWLY DIAGNOSED MULTIPLE MYELOMA
Feb 25, 2026, 14:43 PM -
FRAMEWORK FOR RWD TRANSFORMATIONS FROM NATIVE DATA MODELS TO CDISC DATA STANDARDS
Feb 25, 2026, 14:43 PM -
EVALUATING THE ECONOMIC VALUE OF MONOCLONAL ANTIBODIES FOR AQP4+ NMOSD IN THE US USING ATTACK-FREE SURVIVAL OVER A 5-YEAR HORIZON
Feb 25, 2026, 14:43 PM -
UNDERSTANDING THE GLOBAL ECONOMIC BURDEN OF HEPATITIS DELTA VIRUS: A SYSTEMATIC LITERATURE REVIEW
Feb 25, 2026, 14:43 PM -
REPRESENTATIVENESS OF LINKED CLAIMS-EHR DATA: CLAIMS-ONLY VS CLAIMS+EHR POPULATIONS
Feb 25, 2026, 14:43 PM -
RENAL RISK STRATIFICATION IN ON-PUMP AND OFF-PUMP CORONARY ARTERY BYPASS SURGERY
Feb 25, 2026, 14:43 PM -
BIREOCICLIB PLUS FULVESTRANT FOR HR+/HER2- ADVANCED OR METASTATIC BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS
Feb 25, 2026, 14:43 PM -
REAL-WORLD SURVIVAL OUTCOMES IN KRAS(G12C) METASTATIC COLORECTAL CANCER IN THE UNITED STATES AND CANADA: A SYSTEMATIC LITERATURE REVIEW
Feb 25, 2026, 14:43 PM -
USING SOCIAL DETERMINANTS OF HEALTH ICD-10 Z-CODES TO IDENTIFY NON-MEDICAL FACTORS AMONG ASTHMA HOSPITALIZATIONS IN THE UNITED STATES, 2016-2022
Feb 25, 2026, 14:43 PM -
TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND DIRECT MEDICAL COSTS OF CHRONIC URTICARIA IN CHINA: A REAL-WORLD STUDY
Feb 25, 2026, 14:43 PM -
IMPACT OF KP.2 BNT162B2 COVID-19 VACCINE ON ACUTE SYMPTOMS AMONG U.S. ADULTS DURING THE 2024-2025 RESPIRATORY SEASON
Feb 25, 2026, 14:43 PM -
ENHANCING LONG-TERM COST-EFFECTIVENESS PROJECTIONS USING REAL-WORLD EVIDENCE-INFORMED UNCERTAINTY ANALYSIS
Feb 25, 2026, 14:43 PM -
FROM INTENTION TO IMPLEMENTATION: A SYSTEMATIC REVIEW OF THE SOCIETAL PERSPECTIVE IN COST-EFFECTIVENESS ANALYSES OF NON-SMALL CELL LUNG CANCER THERAPIES
Feb 25, 2026, 14:43 PM -
BREAKING BARRIERS IN CANCER IMMUNOTHERAPY: MECHANISTIC INSIGHTS INTO RESISTANCE AND IMPLICATIONS FOR HEALTH ECONOMICS AND OUTCOMES RESEARCH (HEOR) AND VALUE ASSESSMENT
Feb 25, 2026, 14:43 PM -
GEOGRAPHIC AND TEMPORAL TRENDS IN ADULT DIABETES PREVALENCE, UNITED STATES, 2011-2021
Feb 25, 2026, 14:43 PM -
A REAL-WORLD US COMMUNITY-BASED EVALUATION OF RECURRENCE AMONG INTERMEDIATE RISK NON-MUSCLE-INVASIVE BLADDER CANCER PATIENTS TREATED WITH BACILLUS CALMETTE-GUERIN
Feb 25, 2026, 14:43 PM -
PSYCHOSOCIAL CORRELATES OF HEALTH ANXIETY IN A HEALTHY ADULT POPULATION
Feb 25, 2026, 14:43 PM -
IDENTIFYING DRUG REPURPOSING OPPORTUNITIES WITH AI THROUGH LITERATURE REVIEW: A STRUCTURED APPROACH FOR DETECTING NOVEL THERAPEUTIC SIGNALS IN PUBLISHED STUDIES
Feb 25, 2026, 14:43 PM -
ECONOMIC EVALUATION OF SACITUZUMAB GOVITECAN AMONG METASTATIC TRIPLE-NEGATIVE BREAST CANCER PATIENTS: A SYSTEMATIC LITERATURE REVIEW
Feb 25, 2026, 14:43 PM
